Kukje Pharma Co., Ltd. (KRX:002720)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,990.00
+300.00 (6.40%)
Mar 5, 2026, 12:00 PM KST
1.63%
Market Cap 95.50B
Revenue (ttm) 173.80B
Net Income (ttm) 7.14B
Shares Out 20.36M
EPS (ttm) 350.36
PE Ratio 13.39
Forward PE n/a
Dividend 30.00 (0.62%)
Ex-Dividend Date Mar 12, 2026
Volume 740,835
Average Volume 681,421
Open 4,865.00
Previous Close 4,690.00
Day's Range 4,850.00 - 5,140.00
52-Week Range 4,050.00 - 5,470.00
Beta 0.54
RSI 54.53
Earnings Date Mar 19, 2026

About Kukje Pharma

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAID... [Read more]

Sector Healthcare
Founded 1959
Employees 248
Stock Exchange Korea Stock Exchange
Ticker Symbol 002720
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.